“…Prognosis is poor, with a mortality rate of up to 70-92%, (average 50%); however, a trend in the reduction of mortality was observed in the recent years, likely due to a better knowledge of the disorder, a more rapid diagnosis and a precocious introduction of novel, targeted therapies [8]. Older age, longer lupus disease duration, acute massive hemoptysis, requirement of mechanical ventilation and plasmapheresis treatment, thrombocytopenia (not universally accepted) and infections are associated with an increased risk of mortality [8,10,41]. However, severe diseases rendered the requirement of plasmapheresis treatment and mechanical ventilation are themselves associated with poor outcome.…”